Jake Javier - participant in the SCIStar study The beginning of a clinical trial, particularly the first time a new therapy is being tested in people, is often a time of equal parts anticipation and nervousness. Anticipation, because you have been working to this point for many years. Nervousness, because you have never tested this … Continue reading One year later, spinal cord therapy still looks promising
Ed Wirth
New Results Offer Hope for People with Spinal Cord Injuries
Kris Boesen, CIRM spinal cord injury clinical trial patient works to strengthen his upper body. (Photo/Greg Iger) A spinal cord injury can change a life in an instant. For many years, treatment options focused on rehabilitation, pain management, and maximizing remaining function. Today, regenerative medicine offers new possibilities. Recent results from a CIRM-supported clinical trial … Continue reading New Results Offer Hope for People with Spinal Cord Injuries
CIRM-funded stem cell clinical trial for spinal cord injury expands patient recruitment
It’s always great to start the week off with some good news. Today we learned that the Food and Drug Administration (FDA) has given Asterias Biotherapeutics approval to expand the number and type of people with spinal cord injuries that it treats in their CIRM-funded clinical trial. Up till now, Asterias has been treating people … Continue reading CIRM-funded stem cell clinical trial for spinal cord injury expands patient recruitment